Abstract
Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Current Enzyme Inhibition
Title: Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?
Volume: 7 Issue: 2
Author(s): Vaclava Bauerova, Zuzana Vinterova, Iva Pichova and Olga Hruskova-Heidingsfeldova
Affiliation:
Keywords: Aspartic proteinase, Candida spp, GPI-anchored protein, IA3, Saccharomyces cerevisiae, secreted proteinase, vacuole, virulence factors, antimycotics, mycoses
Abstract: Pathogenic yeasts of the genus Candida represent a serious threat to immunocompromised individuals. Soluble secreted aspartic proteinases produced by these opportunistic pathogens have been studied as one of the virulence factors and potential target for therapeutic intervention. Several structures of these enzymes in complex with inhibitors have been published; however, only a limited number of novel inhibitory compounds have been reported recently. Other members of aspartic proteinase family received less attention, although they are important for Candida survival in the host environment. Proteinases attached to the cell surface by GPI-anchor, as well as vacuolar aspartic proteinases may thus become promising therapeutic targets. This review summarizes the data available on less studied aspartic proteinases of C. albicans, and poses the question, whether the knowledge of vacuolar and GPI-anchored aspartic proteinases from Saccharomyces cerevisiae can inspire design of compounds inhibiting these types of enzymes in the pathogenic yeasts.
Export Options
About this article
Cite this article as:
Bauerova Vaclava, Vinterova Zuzana, Pichova Iva and Hruskova-Heidingsfeldova Olga, Intracellular and Extracellular Aspartic Proteinases of Pathogenic Candida Species: Can their Inhibitors be Further Developed?, Current Enzyme Inhibition 2011; 7 (2) . https://dx.doi.org/10.2174/157340811796575263
DOI https://dx.doi.org/10.2174/157340811796575263 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Design, Synthesis, <i>In Silico</i> and <i>In Vitro</i> Studies of Substituted 1, 2, 3, 4- Tetrahydro Pyrimidine Phosphorus Derivatives
Combinatorial Chemistry & High Throughput Screening Effects of Gene and Plasma Tau on Cognitive Impairment in Rural Chinese Population
Current Alzheimer Research Phage Display as a Tool for Protease Ligand Discovery
Current Pharmaceutical Biotechnology SNP-Mediated Neuroprotection under Glucose Deprivation Is Enhanced by Hypericum perforatum
CNS & Neurological Disorders - Drug Targets Inflammation and Age-Related Iron Accumulation in F344 Rats
Current Aging Science Toxicological Effects of Dietary Biogenic Amines
Current Nutrition & Food Science Tea Consumption and Risk of Ischemic Stroke: a Brief Review of the Literature
Current Pharmaceutical Biotechnology Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions
CNS & Neurological Disorders - Drug Targets RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry Brain Tumor Causes, Symptoms, Diagnosis and Radiotherapy Treatment
Current Medical Imaging Changes in Cannabinoid Receptor Subtype 1 Activity and Interaction with Metabotropic Glutamate Subtype 5 Receptors in the Periaqueductal Gray- Rostral Ventromedial Medulla Pathway in a Rodent Neuropathic Pain Model
CNS & Neurological Disorders - Drug Targets Acridine and Acridone Derivatives, Anticancer Properties and Synthetic Methods: Where Are We Now?
Anti-Cancer Agents in Medicinal Chemistry Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts
Current Neuropharmacology Policies to Prevent Tobacco Use and Exposure in Children, a Global Perspective
Current Pediatric Reviews Gliomagenesis and the Use of Neural Stem Cells in Brain Tumor Treatment
Anti-Cancer Agents in Medicinal Chemistry Matrix Metalloproteinase-2 and Epidermal Growth Factor are Decreased in Platelets of Alzheimer Patients
Current Alzheimer Research An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research Psychiatric Polypharmacy, Etiology and Potential Consequences
Current Psychopharmacology Imaging of the Colon in Inflammatory Bowel Disease: Ready for Prime Time?
Current Drug Targets Drugs of Abuse: Epigenetic Mechanisms in Toxicity and Addiction
Current Medicinal Chemistry